The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Personal Genome Testing-Global Market Insights and Sales Trends 2025
Synopsis
The global Personal Genome Testing market size is expected to reach US$ 3178.8 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Personal Genome Testing in various end use industries. The expanding demands from the Neurological Disorders, Oncology, Metabolic Disorders and Autoimmune Disorders, are propelling Personal Genome Testing market. Targeted Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Targeted Testing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Personal Genome Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Personal Genome Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Personal Genome Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Personal Genome Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Personal Genome Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Personal Genome Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Personal Genome Testing covered in this report include 23andMe, Inc., Navigenics, deCODEme, Color Genomics, Inc., Personal Genome Diagnostics, Inc., Counsyl, Inc., Quest Diagnostics and Gene By Gene, Ltd., etc.
The global Personal Genome Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
23andMe, Inc.
Navigenics
deCODEme
Color Genomics, Inc.
Personal Genome Diagnostics, Inc.
Counsyl, Inc.
Quest Diagnostics
Gene By Gene, Ltd.
Global Personal Genome Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Personal Genome Testing market, Segment by Type:
Targeted Testing
Non-Targeted Testing
Multi-Targeted Testing
Global Personal Genome Testing market, by Application
Neurological Disorders
Oncology
Metabolic Disorders
Autoimmune Disorders
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Personal Genome Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Personal Genome Testing market size is expected to reach US$ 3178.8 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Personal Genome Testing in various end use industries. The expanding demands from the Neurological Disorders, Oncology, Metabolic Disorders and Autoimmune Disorders, are propelling Personal Genome Testing market. Targeted Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Targeted Testing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Personal Genome Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Personal Genome Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Personal Genome Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Personal Genome Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Personal Genome Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Personal Genome Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Personal Genome Testing covered in this report include 23andMe, Inc., Navigenics, deCODEme, Color Genomics, Inc., Personal Genome Diagnostics, Inc., Counsyl, Inc., Quest Diagnostics and Gene By Gene, Ltd., etc.
The global Personal Genome Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
23andMe, Inc.
Navigenics
deCODEme
Color Genomics, Inc.
Personal Genome Diagnostics, Inc.
Counsyl, Inc.
Quest Diagnostics
Gene By Gene, Ltd.
Global Personal Genome Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Personal Genome Testing market, Segment by Type:
Targeted Testing
Non-Targeted Testing
Multi-Targeted Testing
Global Personal Genome Testing market, by Application
Neurological Disorders
Oncology
Metabolic Disorders
Autoimmune Disorders
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Personal Genome Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Personal Genome Testing
1.1 Personal Genome Testing Market Overview
1.1.1 Personal Genome Testing Product Scope
1.1.2 Personal Genome Testing Market Status and Outlook
1.2 Global Personal Genome Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Personal Genome Testing Market Size by Region (2018-2029)
1.4 Global Personal Genome Testing Historic Market Size by Region (2018-2023)
1.5 Global Personal Genome Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Personal Genome Testing Market Size (2018-2029)
1.6.1 North America Personal Genome Testing Market Size (2018-2029)
1.6.2 Europe Personal Genome Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Personal Genome Testing Market Size (2018-2029)
1.6.4 Latin America Personal Genome Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Personal Genome Testing Market Size (2018-2029)
2 Personal Genome Testing Market by Type
2.1 Introduction
2.1.1 Targeted Testing
2.1.2 Non-Targeted Testing
2.1.3 Multi-Targeted Testing
2.2 Global Personal Genome Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Personal Genome Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Personal Genome Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Personal Genome Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Personal Genome Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Personal Genome Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Personal Genome Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Personal Genome Testing Revenue Breakdown by Type (2018-2029)
3 Personal Genome Testing Market Overview by Application
3.1 Introduction
3.1.1 Neurological Disorders
3.1.2 Oncology
3.1.3 Metabolic Disorders
3.1.4 Autoimmune Disorders
3.1.5 Others
3.2 Global Personal Genome Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Personal Genome Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Personal Genome Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Personal Genome Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Personal Genome Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Personal Genome Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Personal Genome Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Personal Genome Testing Revenue Breakdown by Application (2018-2029)
4 Personal Genome Testing Competition Analysis by Players
4.1 Global Personal Genome Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Personal Genome Testing as of 2022)
4.3 Date of Key Players Enter into Personal Genome Testing Market
4.4 Global Top Players Personal Genome Testing Headquarters and Area Served
4.5 Key Players Personal Genome Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Personal Genome Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 23andMe, Inc.
5.1.1 23andMe, Inc. Profile
5.1.2 23andMe, Inc. Main Business
5.1.3 23andMe, Inc. Personal Genome Testing Products, Services and Solutions
5.1.4 23andMe, Inc. Personal Genome Testing Revenue (US$ Million) & (2018-2023)
5.1.5 23andMe, Inc. Recent Developments
5.2 Navigenics
5.2.1 Navigenics Profile
5.2.2 Navigenics Main Business
5.2.3 Navigenics Personal Genome Testing Products, Services and Solutions
5.2.4 Navigenics Personal Genome Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Navigenics Recent Developments
5.3 deCODEme
5.3.1 deCODEme Profile
5.3.2 deCODEme Main Business
5.3.3 deCODEme Personal Genome Testing Products, Services and Solutions
5.3.4 deCODEme Personal Genome Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Color Genomics, Inc. Recent Developments
5.4 Color Genomics, Inc.
5.4.1 Color Genomics, Inc. Profile
5.4.2 Color Genomics, Inc. Main Business
5.4.3 Color Genomics, Inc. Personal Genome Testing Products, Services and Solutions
5.4.4 Color Genomics, Inc. Personal Genome Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Color Genomics, Inc. Recent Developments
5.5 Personal Genome Diagnostics, Inc.
5.5.1 Personal Genome Diagnostics, Inc. Profile
5.5.2 Personal Genome Diagnostics, Inc. Main Business
5.5.3 Personal Genome Diagnostics, Inc. Personal Genome Testing Products, Services and Solutions
5.5.4 Personal Genome Diagnostics, Inc. Personal Genome Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Personal Genome Diagnostics, Inc. Recent Developments
5.6 Counsyl, Inc.
5.6.1 Counsyl, Inc. Profile
5.6.2 Counsyl, Inc. Main Business
5.6.3 Counsyl, Inc. Personal Genome Testing Products, Services and Solutions
5.6.4 Counsyl, Inc. Personal Genome Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Counsyl, Inc. Recent Developments
5.7 Quest Diagnostics
5.7.1 Quest Diagnostics Profile
5.7.2 Quest Diagnostics Main Business
5.7.3 Quest Diagnostics Personal Genome Testing Products, Services and Solutions
5.7.4 Quest Diagnostics Personal Genome Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Quest Diagnostics Recent Developments
5.8 Gene By Gene, Ltd.
5.8.1 Gene By Gene, Ltd. Profile
5.8.2 Gene By Gene, Ltd. Main Business
5.8.3 Gene By Gene, Ltd. Personal Genome Testing Products, Services and Solutions
5.8.4 Gene By Gene, Ltd. Personal Genome Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Gene By Gene, Ltd. Recent Developments
6 North America
6.1 North America Personal Genome Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Personal Genome Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Personal Genome Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Personal Genome Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Personal Genome Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Personal Genome Testing Market Dynamics
11.1 Personal Genome Testing Industry Trends
11.2 Personal Genome Testing Market Drivers
11.3 Personal Genome Testing Market Challenges
11.4 Personal Genome Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
